as on March 9, 2026 at 9:31 pm IST
Day's Low
Day's High
15.38%
Downside
8.13%
Upside
52 Week's Low
52 Week's High
74.91%
Downside
8.13%
Upside
as on March 9, 2026 at 4:01 pm IST
Market Cap
₹1,141.42 Cr
Return on Equity (ROE)
13.36
PE Ratio (TTM)
41.96
Return on capital employed (ROCE)
17.49
Industry PE ratio
42.07
Beta (LTM)
0.22
P/B Ratio
2.4
Dividend Yield
0.47
PEG Ratio
36.68
Quarterly Earnings Growth YOY
107.11
EPS (TTM)
4.422
Sector
Pharmaceuticals
Book Value
37.13
Technical Analysis
Bullish
View Technical Analysis
as on March 9, 2026 at 4:01 pm IST
Titan Biotech in the last 5 years
Lowest (3.20x)
June 30, 2020
Today (41.96x)
March 6, 2026
Industry (42.07x)
March 6, 2026
Highest (48.65x)
October 15, 2025
Today’s Price to Earnings Ratio: 41.96x
Compare market cap, revenue, PE, and other key metrics of Titan Biotech with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 1,141.42 | 119.38% | 0.51 | 18 | 156 | |
| NA | 77.51 | -11.4% | 0.00 | 9 | 131 | |
| BUY | 4,059.68 | 143.13% | 0.70 | -57 | 292 | |
| BUY | 27,497.85 | -6.67% | 0.53 | 698 | 5,616 | |
| NA | 84.97 | -7.26% | 0.71 | 10 | 120 |
Search interest for Titan Biotech Ltd Stock has increased by 192% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:192% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Titan Biotech.
Titan Biotech Ltd’s net profit jumped 94.31% since last year same period to ₹8.53Cr in the Q3 2025-2026. On a quarterly growth basis, Titan Biotech Ltd has generated 9.92% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Titan Biotech Ltd has declared dividend of ₹2.00 per share on 30 May 2025 - translating a dividend yield of 0.72%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 4 quarters, 4.05 Cr → 8.53 Cr (in ₹), with an average increase of 20.5% per quarter
Revenue Rich
![]()
Revenue is up for the last 4 quarters, 36.55 Cr → 57.76 Cr (in ₹), with an average increase of 13.8% per quarter
Price Rise
![]()
In the last 7 days, Titan Biotech stock has moved up by 25.5%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 55.78% of holdings in Dec 2025 quarter
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 44.19% of holdings in Dec 2025 quarter
| Organisation | Titan Biotech Ltd |
| Headquarters | New Delhi |
| Industry | Pharmaceuticals |
| CEO | Rohit Jain |
| E-voting on shares | Click here to vote |
Titan Biotech share price today stands at ₹297.8 as on at the close of the market. Titan Biotech share today touched a day high of ₹322 and a low of ₹252.
Titan Biotech touched a 52 week high of ₹322 and a 52 week low of ₹74.73. Titan Biotech share price today i.e. is closed at ₹297.8, which is -7.52% down from its 52 week high and 298.50% up from its 52 week low.
Titan Biotech market capitalisation is ₹1,141.42 Cr as on .
To buy Titan Biotech shares, you need to follow these steps:
Titan Biotech trading volume is 3.94L as on . This means that 3.94L shares of Titan Biotech were bought and sold on the stock market during today's trading session.